Dr. Cheng is a Cardiologist and Instructor at Stanford University School of Medicine in the Department of Medicine. Dr. Cheng received his BEng in Chemical Engineering and BSc in biology at MIT. He subsequently completed his MD/PhD at UCSF working in the Srivastava lab studying how extracellular morphogenic signals affect cardiac development and fate determination of cardiac progenitors. After finishing an internal medicine residency at Stanford, Paul has continued at Stanford as a fellow in cardiology. He is currently investigating molecular mechanisms behind genetic risk factors for human cardiovascular disease with a keen interest in amyloidosis, cardio-oncology, and atherosclerotic diseases. His current research focuses on the transcriptional regulation in smooth muscle cells utilizing both in vitro and in vivo models in combination with single-cell technologies to gain further insights into mechanisms that underlies genetic contributions to risk of human vascular and atherosclerotic diseases.